Hormonal
Obesity (BMI ≥30 kg/m²) significantly impairs female fecundity and increases the risk of miscarriage through hormonal perturbations (elevated leptin, insulin resistance, altered SHBG) and direct effects on oocyte quality and endometrial receptivity.
If you have a BMI over 30, your risk of infertility and miscarriage is significantly higher due to hormonal imbalances like high leptin and insulin resistance. However, this is not permanent. Losing weight, even modestly (5% or more), can restore normal ovulation and significantly improve your chances of conceiving naturally or through assisted reproduction. Consult a specialist for a weight management plan tailored to fertility.
Obese women are three times more likely to suffer infertility than women with a normal body mass index (BMI; Rich-Edwards et al. 1994)... Obesity impairs ovulation but has also been observed to detrimentally affect endometrial development and implantation.
Why this rating
The paper cites multiple large population studies, meta-analyses, and retrospective analyses, though it notes some heterogeneity in study designs regarding oocyte quality.
Source
The adverse effects of obesity on conception and implantation
Christopher Brewer et al. · Reproduction · 2010
DOI 10.1530/rep-09-0568
More from this paper
- Elevated leptin levels in obesity disrupt the hypothalamic-pituitary-ovarian (HPO) axis, inhibiting folliculogenesis and oocyte maturation, thereby reducing fecundity.Good
- Obesity reduces oocyte quality and maturity, leading to lower fertilization rates and increased miscarriage, independent of the number of follicles developed.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →